about
The interaction of angiocidin with tissue transglutaminaseThe nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury.Genetic deletion of transglutaminase 2 does not rescue the phenotypic deficits observed in R6/2 and zQ175 mouse models of Huntington's disease.Crystal structure of transglutaminase 2 with GTP complex and amino acid sequence evidence of evolution of GTP binding site.MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response.Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence.Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Transglutaminase 2 inhibitors and their therapeutic role in disease states.Fission yeast Cyk3p is a transglutaminase-like protein that participates in cytokinesis and cell morphogenesis.Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors.Potential of transglutaminase 2 as a therapeutic target.TG2, a novel extracellular protein with multiple functions.Crystallization and preliminary X-ray crystallographic studies of transglutaminase 2 in complex with Ca2+.Structural aspects of transglutaminase 2: functional, structural, and regulatory diversity.A profiling platform for the characterization of transglutaminase 2 (TG2) inhibitors.Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family.
P2860
Q24318943-F7686D06-7D08-474E-97B5-60E7EBA71A45Q24815528-4DDF9C69-398F-4169-A251-F8452AB3DC02Q33325485-6B34A4A1-DDAA-40B5-A917-8D2998AB45BBQ33793353-CC33BAB7-4CFF-4965-AF8D-BC5726BBD029Q34142460-8F411DC5-1598-48AA-87DF-023FEED77778Q34154917-F4F7FC43-64D2-4CFF-95B1-7BFF610280B0Q34994693-14009090-92DD-4B74-8B7A-918061C3DBD7Q35622533-8FD0AFB3-AE33-476F-8F0A-DFCBD6D33E6EQ35989247-4FC3DACD-94ED-4898-87D7-C41E59CA3C66Q36066623-3577DF0F-178B-4EDC-B817-6AC8CD1728BEQ37263038-7779E32F-4F1E-45AE-B7B0-E3E8B73BDD28Q37776508-6AE03BF2-E9AF-4A89-9703-FF0D8D8DE166Q37912042-118C5BC0-6152-4149-8814-68A05D761BF0Q38618937-C8537B8F-A9FD-45A5-9A5E-248AB74D1D79Q39414447-6E137388-55C8-48AF-8D40-076A6A1BFD6EQ39714317-58A4AF6C-BEB0-421B-B0CE-0DE92F5BA1D3Q55499802-B0EE9AFD-99B1-4CB4-8881-74F65909D523
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Tissue transglutaminase (TG2) in cancer biology.
@ast
Tissue transglutaminase (TG2) in cancer biology.
@en
type
label
Tissue transglutaminase (TG2) in cancer biology.
@ast
Tissue transglutaminase (TG2) in cancer biology.
@en
prefLabel
Tissue transglutaminase (TG2) in cancer biology.
@ast
Tissue transglutaminase (TG2) in cancer biology.
@en
P356
P1476
Tissue transglutaminase (TG2) in cancer biology.
@en
P2093
Kapil Mehta
Lingegowda S Mangala
P304
P356
10.1159/000084237
P577
2005-01-01T00:00:00Z